Core Viewpoint - China Resources Pharmaceutical (03320) is projected to achieve a revenue of 51 billion RMB in its pharmaceutical segment by 2025, reflecting a year-on-year growth of 10.2% [1] Group 1: Revenue and Growth - The traditional Chinese medicine segment is expected to maintain double-digit growth, with a year-on-year increase of 13.0%, generating 27.4 billion RMB in revenue [1] - The growth rate for Chinese medicine prescription drugs is forecasted at 26.8%, significantly outpacing the OTC growth of 5.6%, driven by the consolidation of Tianjin Pharmaceutical and the structural improvement in cardiovascular products [1] Group 2: Profit Forecast and Valuation - The investment bank has slightly raised its profit forecasts for the group for the next two years, increasing the target price from 5.9 HKD to 6.3 HKD, which corresponds to a projected valuation of less than 10 times for 2026, indicating continued attractiveness [1] Group 3: Management Guidance and Strategic Outlook - Management has not provided specific revenue or profit guidance for the fiscal year 2026 but has communicated qualitative signals: aiming for high single-digit revenue growth and good net profit growth [1] - The dividend payout ratio is expected to remain at 30%, with potential increases if no major acquisitions occur, referencing the dividend rates of A-share listed companies above 30% [1] - The pressure from impairments is anticipated to significantly decrease in 2025 [1] - The strategy for blood products acquisitions will continue, focusing on appropriate timing, location, and pricing to achieve industry consolidation, entering the blood products sector is seen as strategically significant [1]

Core Viewpoint - The overall sentiment in the liquor industry is cautious as the focus shifts from channel competition to consumer engagement and retention, with 2026 expected to be a pivotal year for the industry [1][2]. Group 1: Liquor Industry Insights - The number of participating companies and personnel at the 2026 Spring Sugar Conference is lower than in previous years, with major companies like Moutai and Wuliangye canceling events, indicating a shift towards C-end user operations and brand value transmission [1][2]. - The liquor sector is still in a bottoming phase, with signs of stabilization from leading companies like Moutai and Wuliangye, while overall demand is expected to normalize post-holiday [2]. - Inventory levels among distributors are gradually normalizing, with major liquor companies actively reducing stock, suggesting a potential for marginal improvement in the second half of 2026 [2]. Group 2: Consumer Goods Sector Insights - In the consumer goods sector, the restaurant chain segment shows significant improvement in Q1 2026, with key players locking in short-term costs [3]. - The dairy sector, represented by companies like Mengniu and Yili, is experiencing modest growth, while beverage leaders such as Nongfu Spring continue to show stable growth [3]. - The snack retail segment is also improving, with same-store sales showing positive trends and new store formats being explored to enhance growth potential [3]. Group 3: Investment Recommendations - The investment strategy emphasizes a focus on cyclical recovery in the restaurant chain sector, recommending companies like Haitian Flavoring and Yanjing Beer for their competitive advantages and growth potential [4]. - In the dairy sector, attention is drawn to leading companies like Yili and Mengniu, as well as upstream suppliers like Youran Dairy, due to improving supply-demand dynamics [4]. - The liquor sector is viewed as a buying opportunity at the bottom, with recommendations for Moutai and Wuliangye based on clearer Q1 expectations and potential price catalysts [4].

Group 1 - The board of directors of China Merchants Securities Asset Management Co., Ltd. guarantees that the information contained in the 2025 annual report of its funds does not contain false records, misleading statements, or significant omissions, and assumes individual and joint responsibility for the authenticity, accuracy, and completeness of its content [1] - A total of 14 funds are mentioned, with the full text of the 2025 annual report to be disclosed on March 27, 2026, on the company's website and the China Securities Regulatory Commission's fund electronic disclosure website for investors to review [1] Group 2 - The fund management company commits to managing and utilizing fund assets with honesty, diligence, and responsibility, but does not guarantee profits or minimum returns [2] - Investors are advised to fully understand the risk-return characteristics of the funds and to make investment decisions prudently [2]

Core Insights - The consumer-grade 3D printing industry is transitioning towards a more accessible creative era for individuals and small businesses, driven by advancements in technology and product offerings [1] Group 1: Market Overview - The global 3D printer market is projected to grow from $2.1 billion in 2024 to $8.8 billion by 2029, with a CAGR of 34% during this period [2] - The shipment and ownership of consumer-grade 3D printers are expected to grow at CAGRs of 27% and 21%, respectively, from 2024 to 2029 [2] - In 2024, the top four companies in the consumer-grade 3D printer market will hold a combined market share of 71%, with Chinese brands accounting for over 95% of global shipments [2] Group 2: Company Performance - Tuozhu is positioned to achieve over $10 billion in revenue by 2025, leveraging its focus on Fused Deposition Modeling (FDM) technology and superior product performance [3] - Tuozhu's printers can achieve speeds of up to 1000 mm/s and precision of 0.01 mm, while maintaining high yield rates and stability [3] - The company has established a complete software and hardware ecosystem, enhancing brand influence and customer repurchase rates [3] Group 3: Industry Structure - The upstream of the consumer-grade 3D printing industry includes essential raw materials and core hardware, such as PLA, ABS, PETG, lasers, motherboards, and DLP light engines [4] - The midstream consists of manufacturers of 3D printers and scanners, while the downstream applications primarily focus on consumer goods, education, and cultural products, accounting for 43%, 34%, and 10% of the market, respectively [4] - Relevant companies in the industry include Sikan Technology (3D scanners), Jinchengzi (laser galvanometers), and Anker Innovation (3D printers) [4]

Group 1 - The core announcement is about the change of the Hong Kong business address of the company to 32nd Floor, One Exchange Square, 8 Connaught Place, Central, Hong Kong [1] - The company assures that all other information remains unchanged [1] - The announcement is made by the board of directors of the company, confirming the accuracy and completeness of the information provided [1][3]

6099 變更香港主要營業地點 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本公司之網站、電子信箱、電話、傳真號碼及其他聯繫方式保持不變。 承董事會命 招商證券股份有限公司 霍達 董事長 中國，深圳 2026年3月23日 於本公告日期，本公司執行董事為霍達先生及朱江濤先生；本公司非執行董事為羅立女 士、劉振華先生、李德林先生、李曉霏先生、黃堅先生、張銘文先生及丁璐莎女士；本 公司職工代表董事為馬小利先生；以及本公司獨立非執行董事為葉熒志先生、張瑞君女 士、陳欣女士、曹嘯先生及豐金華先生。 招商證券股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司於香港的主要營 業地點已變更至「香港中環康樂廣場8號交易廣場一座32樓」，自2026年3月23日起生效。 ...

招商证券股份有限公司 关于变更香港营业地址的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600999 证券简称： 招商证券 编号： 2026－002 招商证券股份有限公司（以下简称"本公司"）香港营业地址变更为：香港 中环康乐广场 8 号交易广场一期 32 楼。本公司其他信息维持不变。 特此公告。 招商证券股份有限公司董事会 2026 年 3 月 23 日 1 ...

Group 1 - The core viewpoint of the report is that Tencent Holdings (0700.HK) maintains a "Buy" rating with a target price of HKD 750.0, indicating confidence in the company's future performance [1] - The company's 4Q25 performance met expectations, showcasing robust core business operations [1] - Increased investment in AI is expected to enhance long-term competitiveness, despite potential short-term profit suppression in FY26E [1] Group 2 - Growth momentum is clearly evident in the gaming, advertising, and cloud business sectors [1] - The Sum-of-the-Parts (SOTP) valuation provides support for the company's stock price [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 上证公告（基金）【2026】566号 为促进招商中证光伏产业交易型开放式指数证券投资基金（以下简称光伏招商，基金代 码:516230）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意招商证券股份有限公司自2026年03月23日起为光伏招商提供主 做市服务。 特此公告。 上海证券交易所 2026年03月20日 ...

Core Viewpoint - Century Huatong (002602.SZ) experienced a closing price of 16.18 yuan, reflecting a decline of 2.82% [1] Group 1: Company Performance - Research analysts from China Merchants Securities, Gu Jia and Xie Xiaoyan, published a report on February 2, stating that Century Huatong is a global leader in mobile gaming with significant profit growth over 25 years [1] - The report maintained a "strongly recommended" investment rating for Century Huatong [1] - On February 3, Century Huatong's stock closed at 20.38 yuan, but the stock price has been fluctuating downward over the following month [1]